0
Products in the cart
Total:
Information block example
Currency
English Support
Request a call
Working hours:
Пн-Пт 9:00—23:00;
Сб-Вс 10:00-20:00

Atazor R

Atazor R (Atazanavir & Ritonavir)

Atazor R tablets are two medicines fixed dose combination with protease inhibitor activity. Atazor R tablets are primarily indicated for the condition like HIV-1 infection. Atazor R tablets are majorly indicated for adolescents.

Feature
Brand name:
Atazor R
Active substance:
Atazanavir 300mg, Ritonavir 100mg
Manufacturer:
Emcure Pharmaceutical Ltd.,
Packaging:
30 Tablets
Product form:
Tablet
In stock
Active substance: Atazanavir & Ritonavir
0 $
Available options:
Amount:
To wishlist
Compared
Consulting:+91(994)0472902
Description

INDICATION

Atazor R tablets are two medicines fixed dose combination with protease inhibitor activity. Atazor R tablets are primarily indicated for the condition like HIV-1 infection. Atazor R tablets are majorly indicated for adolescents.

MECHANISM OF ACTION

Atazor R tablet contains Atazanavir & ritonavir as an active substance.

Atazanavir

Atazanavir is pharmacologically classified as an azapeptide protease inhibitor, this may specifically prohibits the virus specific processing of viral Gag & Gag Pol polyproteins present in HIV-1 infected cells. This may results as stoppage of production of new mature virions.

Ritonavir

Ritonavir is pharmacologically categorized as peptidomimetic prohibitor of HIV-1 protease enzyme. This inhibition process restore the enzyme inadequate for the processing the gag-pol polyprotein precursor which undergoes formation of non infectious immature HIV particles.

PHARMACOKINETIC

Absorption

Atazanavir is quickly absorbed with the Tmax of relatively 2.5 hours. If Atazor R is taken with food, leads to increase bioavailability of Atazanavir and depletes its pharmacokinetic variability. Oral bioavailability is around 60-68%

Distribution

Atazanavir is highly bound to human serum protein nearly 86%. It binds to alpha-1-acid glycoprotein and albumin (89% and 86%) respectively

Metabolism

The major biotransformation pathways like; Monooxygenation Dioxygenation Atazor R is highly metabolized in liver It is metabolized by CYP3A

Elimination

The route of elimination is not known clearly The terminal half life of Atazor R in healthy persons is around 7 hours Hepatic impairment patients 12.1 hours

DOSAGE MANAGEMENT

Dosage And Administration

Atazor R tablets should be administered with food. Depending up on the therapy history of patients or use of other anti-retroviral drugs, the dosage of Atazor R tablets should be recommended. In case of co administration of Atazor R with H2 receptors antagonist or proton pump inhibitors, dose separation should be needed for reducing the impacts. Patients who are treated with earlier virologic failure, Atazanavir without Ritonavir should not be suggested.

Before begin the treatment or during the therapy with Atazanavir

Renal function test should be performed before the therapy starts. Serum creatinine, creatinine clearance, urinalysis should be tested frequently. Hepatic function test also performed before begin the therapy with Atazor R .

Recommended adult dosage
For newly treated patients

The prescribed dose is one Atazor R tablet should be administered orally as once daily with food.

Combinational treatment

Atazor R combined with; Tenofovir H2 receptor antagonist: The dose of H2 receptor antagonist should not be maximized while compared to famotidine 40mg as two times a day. The administration of Atazor R & H2 receptor antagonist has time interval of at least 10 hours after the dose of gastric regulators. Proton pump inhibitors: The dose of proton pump inhibitors should not be maximized while compared to pantoprazole 20mg as two times a day. The administration of Atazor R & proton pump inhibitors has time interval of at least 12 hours after the dose of gastric regulators.

For already treated patients

The prescribed dose is one Atazor R tablet should be administered orally as once daily with food.

Combinational treatment

Do not take Atazor R tablets, if tenofovir & H2 receptor antagonist have taken together. Do not administer Atazor R tablets with efavirenz due to depletion of atazanavir exposure.

Renal & hepatic impairment patients

Renal impeded patients, including serious condition are not made do with hemodialysis; dose change ought not to be required for atazanavir. Therapy newly commenced patients with chronic stage renal disease managed with hemodialysis should getting Atazor R tablets. Atazanavir should not recommended for HIV treated experienced patients with chronic stage renal disease with hemodialysis. The safety of Atazor R tablets should be established in mild or moderate hepatic impaired patients. Severe liver impaired patients, Atazor R should not be recommended

SIDE EFFECTS

Side effects
Abnormalities of cardiac conduction Rash Hyperbillirubemia Advanced renal disease Nephrolithiasis & cholelithiasis

Common side effects
Nausea, Jaundice or scleral icterus, Diarrhea, Fever, depression, Myalgia

Lab abnormalities
Increased AST, ALT Increased bilirubin Increased lipase Increased creatine kinase Increased cholesterol Neutropenia Increased glucose level

Post marketing effects
Edema, pancreatitis, hepatic function abnormalities, cholelithiasis, arthralgia, alopecia, angioedema

PRECAUTION

Cardiac conduction abnormalities
Atazor R receiving patients may suffer with QT prolongation. Prevent the problem by monitoring the ECG levels periodically.
Serious skin reactions
Severe rash are occurs during the therapy with Atazor R tablets. In serious condition stop the therapy.
Hyperbilirubinaemia
Patients who are receiving atazanavir should be suggested with increased bilirubin levels. Dose reduction should not be applicable in long term efficacy. Prevent this worsening condition by monitoring the hepatic enzymes levels during the therapy. In severe condition, the therapy should be discontinued.
Advanced renal failure
In chronic condition, stop the therapy with Atazor R tablets. Nephrolithiasis & cholelithiasis; Atazor R tablets should be postponed or discontinued.
Diabetes mellitus
During the treatment, patient’s blood glucose level should be elevated. Prevent the problem by measuring the blood glucose level frequently during the therapy. Initiate the anti-diabetic medications.
Fat redistribution
Re accumulation of fat in the body occurs during the treatment, this may leads to cause obesity.
Hemophilia
Increased bleeding occurs during protease inhibitor therapy. Caution should be taken.

STORAGE

Atazor R tablet container should be stored at temperature between 20° to 25°C. Do not refrigerator. Keep away from moisture, heat & light

MISSED DOSE

If a patient missed a dose them have the dose as soon as possible before to next dose time or skip the missed dose and follow the normal timing. Please consult with the doctor

Feature
Brand name
Atazor R
Active substance
Atazanavir 300mg, Ritonavir 100mg
Manufacturer
Emcure Pharmaceutical Ltd.,
Packaging
30 Tablets
Product form
Tablet
Strength
100mg, 300mg
Atazor R отзывы
Add a comment
0

We use cookies to make the site better for you! Note: We strongly encourage you to talk with your health care professional about your specific medical condition and treatments. The information contained in this website is meant to be helpful and educati
Lorem Ipsum adalah text contoh digunakan didalam industri pencetakan dan typesetting. Lorem Ipsum telah menjadi text contoh semenjak tahun ke 1500an, apabila pencetak yang kurang terkenal mengambil sebuah galeri cetak dan merobakanya menjadi satu buku spe